PRESNELL SHARON COLLINS (Chief Scientific Officer) sold 12.0% of their position (40K shares) of VIVOSIM LABS, INC. on the open market
Open‑market sale worth $50.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2018ACC: 0001209191-18-058330
Officer· Chief Scientific Officer
Since Aug 2018
-40K
Net shares
Net seller
$50.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−40K
Price / share
$1.27
Trade value
$50.80K
% of position
12.0%
11/8/2018
332.19K→292.19K
Total
Net shares
−40K
Net value
-$50.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/8/2018 | S · Sale | −40K | $1.27 | $50.80K | 12.0% | 332.19K | 292.19K |
| Total | −40K | -$50.80K | ||||||
Derivative Transactions0
No derivative transactions reported